Pol F. Boudes
2012 - Amicus Therapeutics
In 2012, Pol F. Boudes earned a total compensation of $998.2K as Chief Medical Officer at Amicus Therapeutics, a 5% decrease compared to previous year.
Compensation breakdown
Bonus | $114,791 |
---|---|
Option Awards | $500,722 |
Salary | $367,920 |
Other | $14,772 |
Total | $998,205 |
Boudes received $500.7K in option awards, accounting for 50% of the total pay in 2012.
Boudes also received $114.8K in bonus, $367.9K in salary and $14.8K in other compensation.
Rankings
In 2012, Pol F. Boudes' compensation ranked 6,133rd out of 11,487 executives tracked by ExecPay. In other words, Boudes earned more than 46.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,133 out of 11,487 | 47th |
Division Manufacturing | 2,181 out of 4,253 | 49th |
Major group Chemicals And Allied Products | 549 out of 1,198 | 54th |
Industry group Drugs | 373 out of 920 | 60th |
Industry Pharmaceutical Preparations | 294 out of 700 | 58th |
Source: SEC filing on April 26, 2013.
Boudes' colleagues
We found five more compensation records of executives who worked with Pol F. Boudes at Amicus Therapeutics in 2012.
2012
John Crowley
Amicus Therapeutics
Chief Executive Officer
2012
David Lockhart
Amicus Therapeutics
Chief Scientific Officer
2012
William Baird
Amicus Therapeutics
Chief Financial Officer
2012
Bradley Campbell
Amicus Therapeutics
Chief Operating Officer
2012
Daphne Quimi
Amicus Therapeutics